Showing results (1711-1720 of 1,814) with videos related to

Sort By:
Pageof 182
Journal of the American Academy of Dermatology|April 21, 2009
New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne groupDiane Thiboutot, Harald Gollnick, Vincenzo Bettoli, et al.
Molecular Psychiatry|August 30, 2017
Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorderF W Lohoff, J L Sorcher, A D Rosen, et al.
Lung Cancer (Amsterdam, Netherlands)|May 4, 2020
Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutationsMatthias Scheffler, Alessandra Holzem, Anna Kron, et al.
Journal of Animal Science and Biotechnology|April 6, 2026
Early life treatment with Lacticaseibacillus rhamnosus strains drives reduced enteric methane emissions in dairy heifersLaureen Crouzet, William Kelly, Catherine Andrews, et al.
Medicine and Science in Sports and Exercise|June 25, 2026
The Components of Physical Fitness in Adults: A Roundtable Statement by the American College of Sports MedicineDeborah Riebe, Meir Magal, Leonard A Kaminsky, et al.
European Heart Journal|July 4, 2015
Healthy lifestyle interventions to combat noncommunicable disease-a novel nonhierarchical connectivity model for key stakeholders: a policy statement from the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive MedicineRoss Arena, Marco Guazzi, Liana Lianov, et al.
The Lancet. Healthy Longevity|March 3, 2024
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trialJoël Guigay, Cécile Ortholan, Damien Vansteene, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 28, 2022
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit StudyYeh Chen Lee, Madeleine T King, Rachel L O'Connell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2022
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trialY Tao, J Biau, X S Sun, et al.
Bulletin Du Cancer|March 17, 2018
[Expectation about maintenance therapy among the GINECO French ovarian cancer cohort from the European NOGGO/ENGOT-ov22 Expression IV survey]Marianne Lorcet, Alain Lortholary, Jean Emmanuel Kurtz, et al.
Pageof 182